NAPRELAN Overview
NAPROXEN SODIUM
- TABLET, EXTENDED RELEASE; ORAL: EQ 375MG BASE; EQ 750MG BASE
Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).
| FDA application | Dosage Form | Strength | Marketing Status | Company |
|---|---|---|---|---|
| NDA #020353 | TABLET, EXTENDED RELEASE; ORAL | Multiple Strengths | Prescription | STAT TRADE |
